Delivery Order SPE2DB20D3104-SPE2DB24FV5D1
- Not listed
- This federal contract award, valued at $5,148.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award, valued at $30,166.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of DIOVAN HCT 160-25 MG TABLET 90S, a pharmaceutical product, to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,422.92 firm-fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,654.10 firm fixed-price delivery order is for the supply of DIOVAN HCT 320-12.5 MG TAB 90S, a cardiovascular medication. The award is made under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $4,516.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Diovan HCT 320-25 mg tablets, a cardiovascular medication, to support military healthcare programs. This award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $10,296.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562086287 DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication, with a completion date of September 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with a ceiling value of $22,292.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,795.23 firm fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of February 26, 2024. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award, valued at $1,214.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4568172510 DIOVAN HCT 320-12.5 MG TAB 90S, a prescription medication, with a completion date of May 8, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award, valued at $3,857.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Diovan HCT 160-12.5 mg tablets, a cardiovascular medication. This is a firm-fixed-price delivery order contract, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV5D1Delivery Order
This federal contract award, valued at $24,711.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of 4563731881 - DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication, to support military healthcare programs. This award did not have a set-aside designation, indicating open competition. AmerisourceBergen, through its extensive pharmaceutical distribution capabilities, has established itself as a key supplier of essential medical commodities to various federal agencies, particularly the DLA, which oversees the procurement of healthcare products for the Department of Defense and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 2/21/24 |